Search Results

4 articles with title/keywords/abstract containing SELEGILINE ORALLY DISINTEGRATING TABLET

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Community and Long-Term Care Management of Parkinson's Disease in the Elderly: Focus on Monoamine Oxidase Type B Inhibitors

Authors: Chen, Jack J.; Fernandez, Hubert H.

Source: Drugs & Aging, Volume 24, Number 8, 2007 , pp. 663-680(18)

Publisher: Adis International

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

Authors: Jankovic, Joseph; Stacy, Mark

Source: CNS Drugs, Volume 21, Number 8, 2007 , pp. 677-692(16)

Publisher: Adis International

Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease

Authors: Lew, Mark F.; Pahwa, Rajesh; Leehey, Maureen; Bertoni, John; Kricorian, Greg; The Zydis Selegiline Study Group,

Source: Current Medical Research and Opinion, Volume 23, Number 4, April 2007 , pp. 741-750(10)

Publisher: Informa Healthcare

Selegiline orally disintegrating tablets for the treatment of Parkinson’s disease

Author: Lew, Mark F

Source: Expert Review of Neurotherapeutics, Volume 5, Number 6, November 2005 , pp. 705-712(8)

Publisher: Expert Reviews

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A